TESS LINS: Open Payments
NPI 1104434745 · SUN CITY CENTER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,674 in 69 payments from 19 companies in 2025. Trend: 2023 $357 · 2024 $1,498 · 2025 $1,674
Food & beverage: $1,607Education: $67
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $289 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $185 |
| ABBVIE INC. | 11 | $171 |
| UCB, Inc. | 6 | $158 |
| E.R. Squibb & Sons, L.L.C. | 3 | $122 |
| Amgen Inc. | 5 | $114 |
| Novartis Pharmaceuticals Corporation | 5 | $109 |
| Lilly USA, LLC | 4 | $98 |
| Galderma Laboratories, L.P. | 4 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $58 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, Sotyktu, OTEZLA, EBGLYSS, BLU-U, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
